by Elena Iemma | May 13, 2021 | News
PROVIDENCE, RI, May 13, 2021 /PRNewswire/ — EpiVax Therapeutics, Inc. (“EVT”) announces the publication “Multi‑step screening of neoantigens’ HLA and TCR‑interfaces improves prediction of survival” in Scientific Reports. This study demonstrates a superior method...
by Annie De Groot | Jun 28, 2019 | Events
5th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference CICON 2019: Translating Science into Survival Wednesday, September 25 – Saturday, September 28 Espace Grande Arche de la Defense Parvis de la Défense 92044 Paris, France Members of EpiVax...
by Annie De Groot | Jun 28, 2019 | Events
7th Annual Cambridge Healthtech Institute’s Immuno-Oncology Summit Powering Next Generation Targeted Immunotherapies Monday, August 5th – Friday August 9th Westin Boston Waterfront 425 Summer Street Boston, MA 02210 UPDATE: EpiVax Oncology (EO) would like...
by Annie De Groot | Mar 29, 2019 | Events
CIMT 2019 Annual Meeting Tuesday, May 21st – Thursday, May 23rd Rheingoldhalle Congress Center Mainz, Germany Meet members of EpiVax Oncology at the 2019 CIMT meeting, scheduled from May 21-23 at the Rheingoldhalle Congress Center in Mainz, Germany. Every year,...
by Annie De Groot | Mar 28, 2019 | Events
Frontiers in Cancer Immunotherapy Symposium Tuesday, May 14th – Wednesday, May 15th Registration starts at 8:30A.M. on Tuesday The New York Academy of Sciences 7 World Trade Center New York City, New York Meet EpiVax Oncology’s CEO/Co-Founder, Gad Berdugo,...
